Aktie A287410 JEISYS MEDICAL INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Jeisys Medical Inc.

Aktien

A287410

KR7287410005

A287410

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 03.05.2024 		% 5 Tage % 1. Jan.
10 450 KRW -0,48 % Intraday Chart für Jeisys Medical Inc. +11,53 % -0,38 %
11.04. AVAVA kündigt exklusive Vertriebspartnerschaft mit Jeisys Medical Inc. für Korea und Japan an CI
2023 Jeisys Medical Inc. (KOSDAQ:A287410) kündigt einen Aktienrückkauf im Wert von 10.000 Millionen KRW an. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan
AVAVA, Inc. announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc.
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Jeisys Medical Inc.'s Equity Buyback announced on May 15, 2023, has closed with 1,075,838 shares, representing 1.42% for KRW 10,000.85 million.
Imeik Technology Wins Exclusive Rights to Distribute Jeisys’ Aesthetic Equipment in China
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Jeisys Medical Inc. announces an Equity Buyback.
Jeisys Medical Inc. authorizes a Buyback Plan.
Jeisys Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Cynosure KK Enters into Distribution Partnership with Jeisys Medical KK in Japan
Jeisys Medical Inc.(KOSDAQ:A287410) added to S&P Global BMI Index
SACCI Bio Co., Ltd. announced that it expects to receive KRW 2.85 billion in funding from Jeisys Medical Inc.
Jeisys Medical Inc. completed the acquisition of Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others in a reverse merger transaction.
Jeisys Medical Inc. signed a contract to acquire Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others for approximately KRW 300 billion in a reverse merger transaction.
Jeisys Medical Inc. announced that it has received KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners Co., Ltd., LSK Investment
Jeisys Medical Inc. announced that it expects to receive KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners, LSK Investment
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A287410 Aktie
  4. Nachrichten Jeisys Medical Inc.
  5. Andere Sprachen